The new SGLT2 inhibitor Empagliflozin was launched in Trivandrum at Jothydev�s Professional Education CME conducted at Vivanta by Taj, Trivandrum on 24th October 2015. The CME had Dr.K.M Prasanna Kumar, as one of the speakers. Dr.Prasanna Kumar lectured on Empagliflozin-relating the theory of extra glycemic effects to clinical practice. Dr.Jothydev Kesavadev lectured on the much discussed Empa-Reg Outcome study, improving survival in type 2 diabetes. Dr.Shradda Bhure lectured on the next generation SGLT2 inhibitor. The CME had senior doctors including Dr.Balachandran, Dr.Ramesan Pillai, Dr.Vasudevan Potty, Dr.Thomas Titus etc. participating actively in the discussions which followed the lectures.